G rowth and migration of vascular smooth muscle cells (VSMC) are vital factors in the pathogenesis of various cardiovascular diseases, such as atherosclerosis. In response to injury, medial VSMC proliferate and migrate to the intima of the blood vessel and form a lesion. 1 Several mitogens have been implicated in this process, one of which is heparinbinding epidermal growth factor-like growth factor (HB-EGF). 2 Studies have shown that HB-EGF is present in atherosclerotic plaques and that it is a potent mitogenic and chemotactic factor for VSMC. [3] [4] [5] Moreover, macrophage, endothelial cells, and VSMC produce HB-EGF on stimulation, 5 suggesting a critical role for HB-EGF in mediating vascular remodeling.
The biological actions of HB-EGF are mediated through members of the EGF receptor superfamily, EGF receptor (EGFR) also known as erbB1, and erbB4. 5 On activation, these receptors undergo homo-or heterodimerization, followed by activation of intrinsic tyrosine kinase activity, leading to a myriad of signaling events. To this end, EGFR mediates a variety of cellular responses, such as cell proliferation, migration, and differentiation. 6 In addition to numerous cancers, EGFR may be involved in the progression of vascular diseases. 7 Few studies exist on the action of erbB4; however, it mediates proliferation, chemotaxis, and differentiation in some cell lines. 8 -10 The mitogen-activated protein kinases (MAPKs) are a well-documented family of serine/threonine kinases that include extracellular signal-regulating kinase (ERK), p38 MAPK, and c-Jun N-terminal kinase. The ERK cascade is the most characterized, and it mediates proliferative and chemotactic responses in various cells, including VSMC. 11 p38 MAPK is usually associated with stress stimuli but has also been shown to lead to proliferation and migration of VSMC. 12,13 Phosphatidylinositol 3-kinase (PI3K) is a serine/ threonine kinase that phosphorylates phosphatidylinositol to produce PI 3,4P 2 and PI 3,4,5P 3 , thereby activating several downstream kinases, such as Akt/protein kinase B and p70S6 kinase (p70S6K). 14, 15 Akt is involved in cell growth by eliciting cell survival/antiapoptotic effects. 16, 17 It has also been shown to have a role in the proliferation of VSMC. 18 Activation of p70S6K contributes to cell growth by positively regulating mRNA translation and is thought to be a prerequisite for protein synthesis in various cell types, including VSMC. 19 -21 EGFR stimulation by EGF results in ERK activation and growth of VSMC. 22 In addition, EGFR and erbB4 are coupled to PI3K pathways in several cells. 8, 23 However, the signaling mechanism by which HB-EGF mediates growth of VSMC has yet to be defined. In the present study, we examined the signaling mechanisms required for HB-EGF-induced cell growth in VSMC. Here, we show that HB-EGF activates the ERK and PI3K pathways through the EGFR. We further show that these pathways are involved in HB-EGF-induced DNA synthesis in VSMC. 
Methods

Materials
Cell Culture
The thoracic aorta from 12-week-old Sprague-Dawley rats were used to prepare VSMC by the explant method. 24 For experiments, VSMC from passage 3 to 12 at approximately 90% confluence in culture were used after 3 days of serum depletion.
Immunoprecipitation
VSMC were stimulated with HB-EGF at 37°C. The cells were lysed with ice-cold immunoprecipitation buffer as previously described. 25 The cell lysates were centrifuged at 14 000g, and the supernatant was immunoprecipitated with the antibody and protein A/G-agarose at 4°C for 24 hours.
Immunoblotting
Cell lysate or immunoprecipitation lysate was subjected to SDS-PAGE and electrophoretically transferred to a nitrocellulose membrane. 24 The membranes were then exposed to primary antibodies overnight at 4°C. After incubation with the peroxidase-linked secondary antibody for 1 hour at room temperature, immunoreactive proteins were visualized by ECL reagent. 24 
DNA synthesis
After pretreatment with or without inhibitors, VSMC grown on 12-well plates were incubated with HB-EGF and 1 Ci of 3 Hthymidine for 24 hours. After washing with trichloroacetic acid, radioactivity was counted using a scintillation counter. 26 
Statistical Analysis
Student's t test was used for the statistical analysis, and data are represented as meanϮSEM, where nϭ3.
Results
HB-EGF can bind to 2 receptors, EGFR and erbB4. 5 We determined whether these receptors were activated by HB- EGF in cultured VSMC. As shown in Figure 1A , HB-EGF (100 ng/mL) stimulated phosphorylation of the EGFR at Tyr1068 in a time-dependent manner, with maximal phosphorylation occurring at 0.5 to 1 minute. The amount of EGFR was reduced by HB-EGF stimulation as detected by immunoblotting possibly as a result of its degradation after hyperphosphorylation and/or internalization. Also, erbB4 was not tyrosine-phosphorylated by HB-EGF in VSMC as detected by immunoprecipitation followed by immunoblotting with phosphotyrosine antibody (Figure 1B) .
To determine whether members of the MAPK family, ERK and p38 MAPK, were stimulated by HB-EGF, we stimulated VSMC with HB-EGF for the indicated times and concentrations. Figure 2 shows that ERK1/2 phosphorylation was stimulated by HB-EGF in a time- (Figure 2A ) and concentration-dependent ( Figure 2B ) manner, with maximal phosphorylation occurring at 5 to 10 minutes and 1 to 100 ng/mL HB-EGF, respectively. Although p38 MAPK is expressed in our cells, we were unable to detect its phosphorylation by HB-EGF using phospho-specific p38 MAPK antibody ( Figure 2C ).
To determine whether the PI3K pathway is involved in HB-EGF-induced mitogenesis, we first examined the downstream components of PI3K, Akt, and p70S6K. Figure 3A shows that Akt was stimulated in a time-dependent manner, with maximal phosphorylation occurring at 2 to 5 minutes. HB-EGF also induced phosphorylation of p70S6K with maximum phosphorylation at 10 minutes ( Figure 3B ).
To examine whether HB-EGF-induced activation of ERK1/2, Akt, and p70S6K was EGFR dependent, we used a specific inhibitor of EGFR kinase, AG1478, to determine its effects on HB-EGF-induced phosphorylation of the aforementioned kinases. First, we confirmed that AG1478 (2.5 mol/L) did inhibit HB-EGF-induced EGFR phosphorylation ( Figure 4A ). HB-EGF-induced phosphorylation of ERK1/2 and Akt was also blocked by AG1478 pretreatment ( Figures 4B and 4C, respectively) . Similar results were obtained when we examined the inhibition of p70S6K by AG1478 (C.M. Reynolds, MS, and E.D. Motley, PhD, unpublished data, 2001).
To ensure that the ERK and PI3K pathways were actually involved in HB-EGF-induced mitogenesis, we used PD98059, the MEK inhibitor, or the PI3K inhibitor, LY294002, to block activation of ERK and PI3K, respectively. We found that PD98059 (25 mol/L) inhibited HB-EGF-induced phosphorylation of ERK, whereas LY294002 (10 mol/L) had no effect on ERK phosphorylation ( Figure  5A ). Figure 5B shows that LY294002 attenuated HB-EGFinduced phosphorylation of Akt, whereas PD98059 had no effect on HB-EGF-induced Akt phosphorylation. We also examined the effects of these inhibitors on HB-EGF-induced p70S6K phosphorylation and obtained results similar to that of Akt (C.M. Reynolds, MS, and E.D. Motley, PhD, unpublished data, 2001).
To determine whether ERK and PI3K pathways were involved in HB-EGF-induced DNA synthesis, we pretreated VSMC with PD98059 and LY294002 to inhibit each pathway, respectively. The HB-EGF-induced DNA synthesis was significantly inhibited by PD98059 and LY294002, thus indicating essential roles for both ERK and PI3K cascades in HB-EGF-induced mitogenesis ( Figure 6 ).
Discussion
In this study, we showed that HB-EGF activates ERK1/2, Akt, and p70S6K through the EGFR in VSMC. In addition, PD98059 and LY294002, the ERK and PI3K pathway inhibitors, respectively, blocked HB-EGF DNA synthesis. Previous studies have shown that HB-EGF can activate EGFR and erbB4. 5, 8, 27 However, our data show that HB-EGF activates EGFR but not erbB4 in VSMC. We further show that an EGFR kinase inhibitor, AG1478, blocked downstream signaling of ERK, Akt, and p70S6K activated by HB-EGF, suggesting the involvement of the EGFR in HB-EGF-induced DNA synthesis.
ERK1/2 and p38 MAPK both have been shown to be positive regulators of cell growth in VSMC. 13, 28 Our results indicate that whereas HB-EGF induced phosphorylation of ERK1/2, it did not phosphorylate p38 MAPK. We also demonstrated that the MEK inhibitor PD98059 selectively inhibited ERK activation by HB-EGF. Moreover, PD98059 inhibited HB-EGF-induced DNA synthesis in VSMC. Our findings are consistent with a previous publication indicating the requirement of the ERK cascade for EGF-induced growth of VSMC 22 and indicate that the ERK cascade is critical for the mitogenic effect of HB-EGF in VSMC.
PI3K and its downstream kinases (Akt and p70S6K) have also been shown to have positive effects on growth of VSMC. 18, 21, 29, 30 As demonstrated in our present study, HB-EGF induced activation of both Akt and p70S6K through the EGFR in VSMC. Also, HB-EGF-induced Akt and p70S6K phosphorylation was selectively inhibited by a PI3K inhibitor, LY294002, but not by PD98059, confirming the role of PI3K in mediating Akt and p70S6K activation by HB-EGF. Determining the specific involvement of the PI3K and ERK/ MAPK pathways in HB-EGF-induced DNA synthesis may be difficult because both PD98059 and LY294002 inhibited control levels and HB-EGF-induced DNA synthesis. However, these data could be interpreted that both ERK and PI3K pathways may be involved in HB-EGF-induced DNA synthesis in addition to basal DNA synthesis. Recently, similar roles for both cascades were demonstrated in HB-EGFdependent cell survival activated by tumor suppressor p53. 31 It should be noted that several distinct G-protein-coupled receptors "trans"-activate the EGFR through HB-EGF generation. Recently, we and others have shown that this mechanism is also involved in angiotensin II and thrombin-induced ERK activation in VSMC. 32, 33 Taken together, our findings will provide new mechanistic insights by which several risk factors induce vascular remodeling by activating HB-EGF/ EGFR signaling pathways. 
